Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1970 Jul 18;103(2):165–166.

Traitement de l'hyperlipoproténémie essentielle de type II par un nouvel agent thérapeutique, la celluline.

Treatment of no. II type essential hyperlipoproteinemia with a new therapeutic agent, celluline

C Thiffault, M Bélanger, M Pouliot
PMCID: PMC1930418  PMID: 5430055

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eastwood M. A., Girdwood R. H. Lignin: a bile-salt sequestrating agent. Lancet. 1968 Nov 30;2(7579):1170–1172. doi: 10.1016/s0140-6736(68)91643-7. [DOI] [PubMed] [Google Scholar]
  2. Eastwood M. A., Hamilton D. Studies on the adsorption of bile salts to non-absorbed components of diet. Biochim Biophys Acta. 1968 Jan 10;152(1):165–173. doi: 10.1016/0005-2760(68)90018-0. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES